TSE:MFC

Manulife Financial (MFC.TO)

61.73
+0.50 (0.82%)
as of Aug 14, 2026, 8:00:00 pm Market Open.
1631 watching
0
Investor Insights
star iconAug 14, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has shown a solid performance in recent quarters, buoyed by its strong presence in Asia and effective wealth management strategies. However, there are concerns regarding its valuation, as it is perceived to be somewhat overbought, trading over 2x book value with limited earnings growth expected in the near future. Despite these concerns, many experts highlight its decent dividend yield and ongoing growth potential, particularly in its Asian markets. The recent implementation of a tax on MFC products for mainland Chinese residents adds a layer of uncertainty. Overall, the sentiment among analysts is cautiously optimistic, with a call for careful monitoring of market conditions and potential entry points for investment.

consensus icon
Consensus
Cautious
valuation icon
Valuation
Fair Value
review icon
Similar
GWO
DON'T BUY
Sold his holdings when they discovered that it wasn't just an insurance company but was a leveraged product on the US stock market. With 51% of their portfolios still unhedged, you still own a highly leveraged stock market.
HOLD
With declining markets, outlook for this one is not too rosy. Almost down to the march/09 level while the market itself is much higher. Balance sheet has been fortified. Feels the market has positive leanings and this stock will survive and flourish.
SELL
Would recommend selling and as a replacement stock, consider Great West Life (GWO-T). (See Top Picks.) For a financial institution, risk management is a basic core competency in this company does not have a good track record.
WEAK BUY
If interest rates and stock market go up, then MFC will go up. They take premiums and invest in bonds. The bonds roll over and with low interest rates, the returns are terrible. He thinks interest rates will go higher and economy will continue to recover, so he says nibble at it and don’t make it a major position.
DON'T BUY
His concern is their exposure to their equity book. This stock is really a call on the market because if it should continue to be sloppy, they are about 50% hedged on equity exposure. Also it is hard for them to get a return on fixed income.
HOLD
Has been a disappointment. Great sensitivity to the equity market and low interest rates. They will survive but doesn't look like they will improve anytime soon. If you own, look to Average Down at around $12.
HOLD
Feels it is bottoming. The pressure has to be on for them to hold the dividend. Pretty good yield. Have some Far East exposure.
RISKY
MFC was hammered in the last part of June by the stock market and again today because they were hit by write-downs and the bond market. Also saw lousy earnings from SLF. Thinks the stock is oversold today. Would really be taken by surprise if they cut the dividend again. Earnings from on going operations were only a little below guidance – a little soft, but not like the overall numbers. This is the number you want to look at going forward.
RISKY
You may see more dumping at the end of the quarter when mutual funds don’t want to show it in their portfolio. Wouldn’t be surprised if it is not a $1 higher at the end of the week. Believes it is worth more.
DON'T BUY
A stock that is leveraged so heavily to the equity market. We may see a pickup in the sock right now because they just came out with a loss leading up to June. He doesn’t see equity market forging ahead so would not recommend it right now
HOLD
Still trashed. Popped today on news. Some bottom fishing going on with this company. Always a hope that you get into the 20’s again. It should be around the bottom here.
BUY ON WEAKNESS
Long-term this company will survive and prosper. Extremely strong balance sheet and its reserve ratio is amongst the highest in Canada. However, it is fairly sensitive to what happens in the equity market. Lifecos will start reporting in the next week or so and he is possibly expecting some bad news on this one, which could create a buying opportunity.
DON'T BUY
Doesn't like the life insurance space right now. This one is a higher risk than its peers. High degree of earnings sensitivity to the equity market.
DON'T BUY
His concern is that there may be something in the woodwork that we still don’t know about.
BUY
It’s painful to hold. Clients are averaging down. Have lots of leverage to stock markets and interest rates. Will have to increase their reserves in both second and third quarters. Analysts have turned in the towel for this year. In couple of years they can release reserves and that boosts earnings. Buy for two or three years.
Showing 1,441 to 1,455 of 2,284 entries